The in vitro expression of bovine leukemia virus (BLV) in short-term cultured bovine peripheral blood mononuclear cells (PBMC) is associated with increased spontaneous lymphocyte blastogenesis. The purpose of this study was to determine whether intracellular pathways responsible for antigen-or mitogen-induced lymphocyte blastogenesis were also responsible for induction of BLV expression. The protein kinase C (PKC) inhibitor 1-(5-isoquinolinylsulfonyl)-3-methylpiperazine dihydrochloride (3-methyl H7) decreased blastogenesis in a dose-dependent manner, as measured by [3H]thymidine incorporation, in unstimulated, lipopolysaccharide-stimulated and phorbol ester (PMA)-stimulated BLV-infected PBMC. Similarly, 3-methyl H7 decreased BLV expression, as measured by production of gp5l envelope antigen or p24Pag antigen, in BLV-infected PBMC under the same conditions. Using an RNase protection assay, the inhibition of BLV expression by 3-methyl H7 was shown to be due to decreased transcriptional activity. The cyclic GMP-dependent protein kinase and cyclic AMP-dependent protein kinase inhibitor N-(2-guanidinoethyl)-5-isoquinolinesulfonamide (HA1004) did not inhibit either BLV expression or blastogenesis of BLV-infected bovine PBMC. Additional evidence for the PKC-dependent expression of BLV was obtained by using a persistently BLV-infected B-lymphocyte cell line, NBC-13. Activation of PKC by PMA in NBC-13 cells increased BLV expression. 3-methyl H7 decreased the PMA-induced expression of BLV in NBC-13 cells in a dose-dependent manner, whereas HA1004 did not inhibit this expression. These results identify a mechanism for the induction of BLV expression through PKC activation and therefore indicate that latency and replication of BLV is controlled by normal B-lymphocyte intracellular signaling pathways.
animals (12, 19, 20, 42, 56) . Additionally, cultured PBMC from BLV-seropositive cattle affected with PL have been reported to have decreased responses to mitogens because of increased spontaneous [3H]thymidine incorporation (45, 61) . The spontaneous [3H]thymidine incorporation in cultured PBMC from cows with PL can be markedly reduced by anti-BLV serum (57, 59) , and the inhibitory activity of anti-BLV serum can be reversed with purified BLV (59) , which suggests that the spontaneous blastogenic response is viral antigen specific.
The objective of this study was to investigate the mechanism responsible for the in vitro induction of BLV expression, specifically, to determine whether virus expression was influenced by intracellular signaling pathways activated during B-lymphocyte blastogenesis (for reviews, see references 7 and 13). B-lymphocyte activation results in the production of diacylglycerol (DAG) and the release of Ca2+ from intracellular stores within the endoplasmic reticulum. DAG and Ca2+ mobilization stimulate the translocation of protein kinase C (PKC) to an activated membrane-associated state. Phorbol-12-myristate-13-acetate (PMA) and bacterial lipopolysaccharide (LPS) also induce translocation of PKC without Ca2+ mobilization, probably by acting as DAG analogs (8, 23, 44, 62) . Through unknown mechanisms, PKC mediates intracellular alkalinization through activation of Na+/H+ exchange, which in turn leads to increased expression of c-myc, c-fos, and Ta genes and to lymphocyte blastogenesis (40, 53) . PKC can be inhibited by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7); however, H7 also inhibits cyclic GMP-dependent protein kinase (PKG) and cyclic AMP-dependent protein kinase (PKA) (27) . PKG and PKA are selectively inhibited by N-(2-guanidinoethyl)-5-isoquinolinesulfonamide (HA1004), which minimally inhibits PKC (27) and therefore serves as a control for H7 inhibition of PKC. H7 has been shown to inhibit proliferation, interleukin-2 (IL-2) production, and PKC activation in phytohemagglutinin-stimulated bovine PBMC (4) , and it has been shown to inhibit proliferation, IL-2 production, and IL-2 receptor expression in mitogen-stimulated human T cells (3) .
Several studies have reported an effect of PKC on expression of retroviruses. The transcriptional activation of the HTLV-I promoter by Tax and the accumulation of unspliced HTLV-I mRNA have been shown to be decreased by PKC inhibitors (1, 58) . In cell lines chronically infected with human immunodeficiency virus (HIV), PKC activators have been shown to enhance HIV expression and this increased expression can be blocked with PKC inhibitors (10, 25, 37) . Additionally, transactivation of HIV type 1 long terminal repeat-directed gene expression by Tat has been shown to require PKC (28). In the current study, experiments were designed to determine whether activation of PKC stimulated BLV expression and whether inhibition of PKC blocked expression of BLV in cultured bovine PBMC and in the persistently BLV-infected B-lymphocyte cell line NBC-13 (21) .
MATERIALS AND METHODS
Chemicals. LPS (L4516; Sigma Chemical Co., St. Louis, Mo.) was dissolved in culture medium at 1 mg/ml immediately before use. PMA (P8139; Sigma Chemical Co.) was dissolved in dimethyl sulfoxide at 1 mM and stored at -20°C. The protein kinase inhibitor H7 was obtained from Sigma Chemical Co. (15262); however, after completion of the experiments it was determined that this compound was actually 1-(5-isoquinolinylsulfonyl)-3-methylpiperazine dihydrochloride (3-methyl H7). 3-methyl H7 has also been shown to inhibit PKC but only 25% as effectively as H7 (38) . The PKA and PKG inhibitor HA1004 was also obtained from Sigma Chemical Co. (G1274). 3-methyl H7 and HA1004 were dissolved in distilled water at 10 mM and stored at -20°C. 3-(4,5 -Dimethylthiazol-2-yl)-2,5 -diphenyltetrazolium bromide (MTT; thiazolyl blue) (M2128; Sigma Chemical Co.) was dissolved at 5 mg/ml in phosphate-buffered saline (PBS) and stored at 4°C in the dark.
Cell isolations and culture conditions. Four clinically normal BLV-seropositive adult female Holstein cattle affected with PL were studied. Three BLV-seronegative cattle were used as controls. BLV serological status was determined by using a competitive enzyme-linked immunosorbent assay (ELISA) as previously described (51), with reagents kindly supplied by Daniel Portetelle (Faculty of Agronomy, Gembloux, Belgium). Venous blood was collected by using EDTA as an anticoagulant. PBMC were isolated by FicollHypaque (1.077 g/ml) density gradient centrifugation. The mononuclear cell layers were harvested, washed three times with PBS containing 1% bovine serum albumin, and suspended at a concentration of 4 x 106/ml in culture medium (RPMI 1640 with 10% heat-inactivated fetal bovine serum [Hyclone Laboratories, Inc., Logan, Utah], 2 mM L-glutamine, 100 U of penicillin per ml, and 100 p.g of streptomycin per ml). NBC-13 cells (21) Detection of BLV gp5l and p24 expression. Bovine PBMC or NBC-13 cells were cultured in 24-well cell culture plates (Corning Glass Works) for 24 h. The cell culture plates were subsequently frozen at -20°C and then thawed at room temperature. The freeze-thaw cycle was repeated twice more, and then supernatant was assayed for the presence of BLV gp5l or p24. Expression of the BLV envelope glycoprotein gp5l was determined with an antigen-capture ELISA as previously described (50, 51) , using monoclonal antibodies kindly supplied by Daniel Portetelle and with the following modifications. Immulon 2 microtiter plates (Dyantech Laboratories, Inc.) were coated (per well) with 100 ng of monoclonal antibody (MAb) specific for the E epitope of BLV gp5l in 10 mM sodium tetraborate overnight at 4°C and then were washed once with PBST (PBS containing 0.2% Tween 80). Quadruplicate 100-,ul samples of cell culture supernatants-50 p.l of saturation buffer (PBS containing 2% bovine serum albumin and 0.06% sodium azide)-15 p.1 of Tween 80 were added to the plates and incubated for 72 h at 4°C. Plates were washed three times with PBST and then were incubated for 2 h at 4°C with (per well) 100 p.1 of horseradish peroxidase-conjugated MAb specific for either the G epitope (200 ng/ml) or a pool specific for the A, B, B', D, D', and E epitopes (100 ng/ml) of BLV gp5l. Plates were washed four times with PBST and then were incubated for 15 min at room temperature with 100 p.l of TMB solution (0.4 g of tetramethylbenzidine per liter, 0.02% hydrogen peroxide) per well. The colorimetric reaction was stopped by the addition of 100 p.1 of 1 N H2SO4 per well, and OD at 450 nm were measured by using an ELISA plate reader (Dynatech MR 700; Dyantech Laboratories, Inc. Detection of BLV transcription. Bovine PBMC and NBC-13 cells were cultured for 6 and 24 h, respectively. Total cellular RNA was subsequently isolated by cell lysis in 4 M acid guanidinium isothiocyanate solution and phenolchloroform extraction as previously described (9, 52) . BLV transcription was measured by using an RNase protection assay (RPA II; Ambion Inc., Austin, Tex.). Total amount of BLV mRNA (unspliced and spliced) was determined by using an antisense riboprobe complementary to 200 bases in the tax/rex region (nucleotides 7896 to 8095 according to the system of Sagata et al. [54] ) since this sequence is present in all BLV mRNA species. The amount of unspliced BLV mRNA was measured by using an antisense riboprobe complementary to 123 bases in the gag region (nucleotides 895 to 1017 according to the system of Sagata et al. [54] [14] ) was used to control for various amounts of RNA in each assay. The bovine actin sequence was amplified by using the polymerase chain reaction from PBMC genomic DNA derived from a BLV-negative cow. The promoter sequence for the T7 polymerase was included in the 3' primer as previously described (64 (90 to 109% of control at 125 ,uM). BLV gpSl and p24 data were derived after adjusting for the effects of 3-methyl H7 and HA1004 on cell viability. In 24-h cultures, 3-methyl H7 decreased PBMC viability in a dose-dependent manner to 50 to 70% at 100 ,uM 3-methyl H7 but had no effect on NBC-13 cell viability. HA1004 had only minimal effects on (Fig. 3A) . Increased incorporation of [methyl- 3Hlthymidine (approximately five times the spontaneous level) occurred in 48-h LPS-stimulated cultures of PBMC from BLV-seropositive cattle with PL ( Fig. 3A versus 3B) ; 3-methyl H7 slightly decreased and HA1004 slightly increased [methyl-3H]thymidine incorporation in these cultures (Fig. 3B) . PMA increased [methyl-3H]thymidine incorporation to approximately three times the spontaneous level in 48-h cultures of BLV-infected PBMC (Fig. 3A versus 3C) ; 3-methyl H7 dramatically decreased [methyl-3H]thymidine incorporation in PMA-stimulated PBMC cultures, and HA1004 had a similar but less dramatic effect (Fig. 3C ). (Fig. 3D) or without PMA (data not shown).
Effect of PKC inhibition on BLV mRNA expression in bovine PBMC and NBC-13 cells. An RNase protection assay was used to quantitate BLV mRNA expression because of increased sensitivity compared with results of Northern (RNA) blot hybridization. Using this assay, expression of BLV could not be detected in freshly isolated PBMC derived from cattle with PL but could be detected in PBMC after as few as 3 to 4 h of incubation. As shown in a representative autoradiograph of the RNase protection assay (Fig. 4) , in 6-h unstimulated PBMC cultures, 3-methyl H7 decreased both total BLV mRNA expression, as evident by a reduction of the tax/rex signal, and full-length BLV mRNA, as shown by a decrease in the gag signal. Using densitometric analysis, the BLV tax/rex signal was calculated relative to the bovine actin signal for each sample and expressed as the average percentage of control. The effect of 3-methyl H7 and HA1004 on total BLV mRNA expression (tax/rex signal) in 6-h unstimulated PBMC cultures obtained from four individual BLV-seropositive cows affected with PL is summarized in Fig. 5 . 3-methyl H7 decreased total BLV mRNA expression in a dose-dependent manner (36% of control at 100 ,uM), whereas HA1004 increased total BLV mRNA expression (126% of control at 100 ,uM). Similar studies with 24-h PMA-stimulated NBC-13 cells showed that 100 ,uM 3-methyl H7 or HA1004 decreased total BLV mRNA expression to 24 and 75% of control, respectively.
DISCUSSION
The objective of the current study was to investigate the mechanism by which BLV expression is activated during in vitro incubation of infected PBMC. Specifically, we were interested in determining whether activation of PKC stimulated BLV expression and whether inhibition of PKC blocked expression of BLV. PBMC from BLV-seropositive cattle affected with PL were used in this study because BLV expression is more readily detected in cultured PBMC from these cattle (11) . A likely explanation for this fact is that approximately 30% of PBMC from PL cattle are infected with BLV (33) compared with less than 5% in hematologically normal BLV-infected cattle (35, 36 (59, 61) . This spontaneous blastogenesis is thought to be an antigen-specific proliferative response to BLV antigens produced during short-term culture (57, 59 Using the PKC inhibitor 3-methyl H7, we were able to block spontaneous [methyl-3H]thymidine incorporation in 48-h cultures of bovine PBMC from PL cattle. In a dosedependent manner, 3-methyl H7 also decreased expression of BLV gp5l and p24 to less than 50% of control in unstimulated 24-h cultures and reduced total BLV transcription to less than 25% of control in unstimulated 6-h cultures. From these results, it cannot be determined whether the effect of 3-methyl H7 on spontaneous blastogenesis is direct or indirect through decreased expression of BLV antigens.
The effects of 3-methyl H7 on spontaneous [methyl-3H]thymidine incorporation and BLV expression may occur in separate B-lymphocyte subpopulations, since it has been reported that B lymphocytes which spontaneously incorporate [methyl-3H]thymidine can be separated by density gradient centrifugation from B lymphocytes expressing BLV (32). 3-methyl H7 likely inhibits spontaneous blastogenesis as a result of a combination of blocking of BLV expression in infected B lymphocytes with subsequent indirect inhibition of blastogenesis in BLV antigen-specific B lymphocytes and direct inhibition of blastogenesis in BLV antigen-specific lymphocytes exposed to residual antigen.
Effects of the PKC inhibitor 3-methyl H7 were further studied in BLV-infected cells stimulated with known PKC activators, including LPS and PMA, to better understand the relationship between virus expression and lymphocyte blastogenesis. Similar to the results in unstimulated PBMC cultures, 3-methyl H7 caused a dose-dependent decrease in BLV expression in LPS-stimulated 24-h PBMC cultures. In contrast to the effects of 3-methyl H7 on BLV expression, 3-methyl H7 only minimally decreased [methyl-3H]thymidine incorporation in LPS-stimulated 48-h PBMC cultures. Although LPS has been shown to directly activate PKC (8, 62) , activation of PKC does not explain all the effects of LPS (13, 29) . It is probable that 3-methyl H7 only inhibits the LPS-induced responses that are mediated through PKC. In PMA-stimulated cultures, 3-methyl H7 caused a dose-dependent decrease in both [methyl-3H]thymidine incorporation and BLV expression. Interestingly, the PKA and PKG inhibitor HA1004 also decreased [methyl-3H]thymidine incorporation without decreasing BLV expression in PMAstimulated PBMC cultures. In addition, our results demonstrate that activation of PKC with PMA induces BLV expression in the persistently BLV-infected B-lymphocyte cell line NBC-13 (21) , which can be subsequently inhibited in a dose-dependent manner with 3-methyl H7 without affecting [methyl-3H]thymidine incorporation. These results further suggest that the mechanism of 3-methyl H7-mediated inhibition of BLV expression is a direct effect of PKC inhibition rather than an indirect effect of the inhibition of DNA synthesis.
Because BLV mRNA is not readily detected in freshly isolated PBMC (30), activation of BLV expression would likely occur at the transcriptional rather than posttranslational level. Using an RNase protection assay, we have demonstrated that inhibition of PKC results in decreased total BLV transcription. However, these results do not exclude the possibility that PKC is also involved in activa-tion of the trans-regulatory protein Rex and therefore affects mRNA splicing. In an HTLV-I-infected T-cell line, H7 has been reported to block accumulation of unspliced HTLV-I mRNA (1), however, in contrast to our results with BLV, the total amount of viral mRNA did not appear to decrease.
These results identify the involvement of PKC in the initiation of BLV expression in short-term PBMC cultures and PMA-stimulated NBC-13 cells and support the hypothesis that expression of BLV occurs subsequent to activation of PKC when infected B lymphocytes undergo blastogenesis. In vivo, BLV would remain latent until the infected B lymphocyte is exposed to antigen specific for its membrane immunoglobulin. Antigen-induced blastogenesis of the BLVinfected B lymphocyte would activate PKC and initiate expression of BLV. Expression of BLV would subsequently cause production of viral particles, infection of naive B lymphocytes, stimulation of the host immune response, and finally elimination of the BLV-expressing cell because of the presence of cytotoxic anti-BLV antibodies (49) or other yet-to-be-identified effector immune mechanisms. Continual or intermittent rounds of low-level antigen production (below the level of detection) would explain the apparent absence of antigenemia, low levels of mRNA production (30), and persistent high-titered antiviral antibody response in BLV-infected animals. The results of this study have significant implications for the mechanism of induction of BLV expression and for the mechanism of viral latency in BLV infection. The induction of BLV expression by activation of PKC indicates that replication of this oncogenic retrovirus is controlled by normal B-lymphocyte intracellular signaling pathways.
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